Details for 2018818829
Up to date per 02.04.2026
Actions
Details for 2018818829
Granted/Registered
European Patent
22.04.2020 A
17.07.2024 B1
15.06.2017
US
201762520430 P
28.11.2017
US
201762591247 P
29.03.2018
US
201862649856 P
16.05.2018
US
201862672261 P
C07D 471/04 20060101AFI20210216BHEP
Owner
Takeda Pharmaceutical Company Limited1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045JP
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
BROWN, Jason W.c/o Takeda California Inc. 9625 Towne Centre Drive San Diego, CA 92121US
HITCHCOCK, Stephenc/o Takeda California Inc. 9625 Towne Centre Drive San Diego, CA 92121US
HOPKINS, Mariac/o Takeda California Inc. 9625 Towne Centre Drive San Diego, CA 92121US
KIKUCHI, Shota5820 Nancy Ridge Drive San Diego, CA 92121US
MONENSCHEIN, Holgerc/o Takeda California Inc. 9625 Towne Centre Drive San Diego, CA 92121US
REICHARD, Hollyc/o Takeda California Inc. 9625 Towne Centre Drive San Diego, CA 92121US
SCHLEICHER, Kristinc/o Takeda California Inc. 9625 Towne Centre Drive San Diego, CA 92121US
SUN, Huikaic/o Takeda California Inc. 9625 Towne Centre Drive San Diego, CA 92121US
MACKLIN, ToddThree Bryant Park 1095 Avenue of the Americas New York, NY 10036-6797US
Information about Fees